Overview

Effects of CoQ10 on Inflammatory Response in Cardiac Surgery

Status:
Not yet recruiting

Trial end date:
2022-12-31

Target enrollment:
0

Participant gender:
All

Summary

Cardiovascular diseases are the leading causes of death and prescription drug use. Research on certain dietary supplements looks promising as a way to help reduce risk factors. Previous studies showed that CoQ10 levels were decreased in cardiovascular patients and worsening of mitochondrial dysfunction was observed. The overall objective of this study is to determine if supplementing with CoQ10 can reduce inflammatory risk factors in adults with cardiac surgery, independent of other dietary or physical activity changes.

Phase:

N/A

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Nanjing Medical University

Treatments:

Coenzyme Q10
Ubiquinone

Criteria

Inclusion Criteria:

- Adult men and women

- Elective cardiac surgery

- Cardiac surgery on cardiopulmonary bypass

Exclusion Criteria:

- Pregnant or planning on getting pregnant during the study

- Emergency cardiac surgery

- Contain a minimum of 2 traits of metabolic syndrome

- Cardiac surgery without cardiopulmonary bypass